神经退行症中的Rho激酶异型:从细胞功能到治疗点
Chesta Shandilya1, Shalini Mani2
1Centre for Emerging Diseases, Department of Biotechnology, Jaypee Institute of Information Technology, Sector 62, Noida, A-10, 201301, UP, India.
通过改善线粒体健康和神经元功能,针对Rho 激酶 (ROCK) 异形显示出神经退行性疾病 (NDD) 的前景. 抑制ROCK通路可能为帕金森病等疾病提供神经保护
科学领域:
- 细胞生物学
- 神经科学
- 线粒体动力学
背景情况:
- 线粒体对神经元功能至关重要,调节能量,和反应性氧物种 (ROS).
- 适当的线粒体动力学 (裂变,融合,线粒体衰变) 对神经元健康至关重要.
- 功能失调的线粒体与神经退行性疾病 (NDD) 相关,如PD,AD,ALS和HD.
研究的目的:
- 审查Rho激酶 (ROCK) 异型 (ROCK1和ROCK2) 在NDD中的线粒体功能障碍中的作用.
- 突出了针对ROCK异型在NDD中的神经保护的治疗潜力.
主要方法:
- 对ROCK异型,线粒体动力学和NDD的现有文献的审查.
- 分析ROCK1在促进过度线粒体裂变中的作用.
- 通过PTEN对Parkins依赖性线粒细胞的ROCK2抑制的分析.
主要成果:
- ROCK1促进线粒体分裂,导致神经元细胞死亡.
- 这导致线粒体质量控制受损和氧化应激.
- 在临床前的NDD模型中,ROCK异型的抑制显示出神经保护作用.
结论:
- ROCK异型是线粒体动力学和线粒体的关键调节剂,涉及到NDD的发病.
- 通过恢复线粒体功能和减少神经炎症,向ROCK异型为NDD提供了一个有前途的治疗策略.
- 对ROCK抑制的进一步研究可能会导致神经退行性疾病的新疗法.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
10:05Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
相关概念视频
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Amplifying Signals via Enzymatic Cascade
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
